Literature DB >> 21830922

Bayesian approach to noninferiority trials for proportions.

Mark A Gamalo1, Rui Wu, Ram C Tiwari.   

Abstract

Noninferiority trials are unique because they are dependent upon historical information in order to make meaningful interpretation of their results. Hence, a direct application of the Bayesian paradigm in sequential learning becomes apparently useful in the analysis. This paper describes a Bayesian procedure for testing noninferiority in two-arm studies with a binary primary endpoint that allows the incorporation of historical data on an active control via the use of informative priors. In particular, the posteriors of the response in historical trials are assumed as priors for its corresponding parameters in the current trial, where that treatment serves as the active control. The Bayesian procedure includes a fully Bayesian method and two normal approximation methods on the prior and/or on the posterior distributions. Then a common Bayesian decision criterion is used but with two prespecified cutoff levels, one for the approximation methods and the other for the fully Bayesian method, to determine whether the experimental treatment is noninferior to the active control. This criterion is evaluated and compared with the frequentist method using simulation studies in keeping with regulatory framework that new methods must protect type I error and arrive at a similar conclusion with existing standard strategies. Results show that both methods arrive at comparable conclusions of noninferiority when applied to a modified real data set. The advantage of the proposed Bayesian approach lies in its ability to provide posterior probabilities for effect sizes of the experimental treatment over the active control.

Mesh:

Substances:

Year:  2011        PMID: 21830922     DOI: 10.1080/10543406.2011.589646

Source DB:  PubMed          Journal:  J Biopharm Stat        ISSN: 1054-3406            Impact factor:   1.051


  5 in total

1.  Non-inferiority Testing for Risk Ratio, Odds Ratio and Number Needed to Treat in Three-arm Trial.

Authors:  Shrabanti Chowdhury; Ram C Tiwari; Samiran Ghosh
Journal:  Comput Stat Data Anal       Date:  2018-09-15       Impact factor: 1.681

2.  Bayesian Approach for Assessing Non-inferiority in Three-arm Trials for Risk Ratio and Odds Ratio.

Authors:  Shrabanti Chowdhury; Ram C Tiwari; Samiran Ghosh
Journal:  Stat Biopharm Res       Date:  2019-04-22       Impact factor: 1.452

3.  New approaches for testing non-inferiority for three-arm trials with Poisson distributed outcomes.

Authors:  Samiran Ghosh; Erina Paul; Shrabanti Chowdhury; Ram C Tiwari
Journal:  Biostatistics       Date:  2022-01-13       Impact factor: 5.899

4.  Bayesian Equivalence Testing and Meta-Analysis in Two-Arm Trials with Binary Data.

Authors:  Cynthia Kpekpena; Saman Muthukumarana
Journal:  Comput Math Methods Med       Date:  2018-08-08       Impact factor: 2.238

5.  A Bayesian non-inferiority approach using experts' margin elicitation - application to the monitoring of safety events.

Authors:  Camille Aupiais; Corinne Alberti; Thomas Schmitz; Olivier Baud; Moreno Ursino; Sarah Zohar
Journal:  BMC Med Res Methodol       Date:  2019-09-18       Impact factor: 4.615

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.